Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
First Trust Ultra Short Duration Municipal ETF
FUMB
$247M
| $23.9M | ﹤0.01% |
1,194,740
-1,221,834
| -51% | -$24.5M |
|
2502
iShares US Pharmaceuticals ETF
IHE
$1.63B
| $23.9M | ﹤0.01% |
352,427
-764,761
| -68% | -$50.6M |
|
2503
BlackRock MuniYield Quality Fund III
MYI
$718M
| $23.9M | ﹤0.01% |
2,082,544
-1,775,656
| -46% | -$20.2M |
|
2504
Patrick Industries
PATK
$2.91B
| $23.8M | ﹤0.01% |
299,311
-327,344
| -52% | -$23.5M |
|
2505
Vericel Corp
VCEL
$2.35B
| $23.8M | ﹤0.01% |
458,260
-2,137,432
| -82% | -$93.7M |
|
|
AMJ
2506
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $23.8M | ﹤0.01% |
835,589
-1,129,281
| -57% | -$30.4M |
|
2507
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $23.7M | ﹤0.01% |
1,031,516
-1,365,444
| -57% | -$31.4M |
|
2508
SSR Mining
SSRM
$6.08B
| $23.7M | ﹤0.01% |
5,318,377
+1,168,027
| +28% | +$8.14M |
|
2509
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.09B
| $23.7M | ﹤0.01% |
210,947
-206,411
| -49% | -$22.1M |
|
|
EOS
2510
Eaton Vance Enhance Equity Income Fund II
EOS
$1.17B
| $23.7M | ﹤0.01% |
1,175,848
-1,157,414
| -50% | -$22.7M |
|
2511
Vir Biotechnology
VIR
$1.53B
| $23.7M | ﹤0.01% |
2,339,260
-1,913,298
| -45% | -$19.5M |
|
2512
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$889M
| $23.7M | ﹤0.01% |
1,020,363
+108,073
| +12% | +$2.5M |
|
2513
Hertz
HTZ
$480M
| $23.7M | ﹤0.01% |
3,020,444
-1,845,540
| -38% | -$15.1M |
|
2514
iShares MSCI Switzerland ETF
EWL
$2.22B
| $23.6M | ﹤0.01% |
494,877
-730,399
| -60% | -$34.6M |
|
2515
Ultragenyx Pharmaceutical
RARE
$2.46B
| $23.5M | ﹤0.01% |
504,382
-690,716
| -58% | -$32.6M |
|
|
SAGE
2516
DELISTED
Sage Therapeutics
SAGE
| $23.5M | ﹤0.01% |
1,256,445
-484,683
| -28% | -$11.2M |
|
2517
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.04B
| $23.5M | ﹤0.01% |
283,752
-269,228
| -49% | -$21.6M |
|
2518
Capital Group Dividend Value ETF
CGDV
$38.8B
| $23.5M | ﹤0.01% |
723,754
+702,472
| +3,301% | +$21.6M |
|
|
NCV
2519
Virtus Convertible & Income Fund
NCV
$383M
| $23.5M | ﹤0.01% |
1,759,632
-1,714,976
| -49% | -$22.5M |
|
2520
Atour Lifestyle Holdings
ATAT
$4.74B
| $23.5M | ﹤0.01% |
1,308,751
+1,054,647
| +415% | +$19.4M |
|
2521
Gildan
GIL
$10.8B
| $23.5M | ﹤0.01% |
631,753
-705,697
| -53% | -$24M |
|
|
ACH
2522
Accendra Health
ACH
$233M
| $23.4M | ﹤0.01% |
844,006
-1,125,082
| -57% | -$25M |
|
2523
Invesco Semiconductors ETF
PSI
$2.44B
| $23.4M | ﹤0.01% |
414,413
-404,229
| -49% | -$21M |
|
2524
iShares MSCI Australia ETF
EWA
$1.44B
| $23.4M | ﹤0.01% |
947,666
-738,122
| -44% | -$17.6M |
|
|
BSJP
2525
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $23.3M | ﹤0.01% |
1,017,316
-257,774
| -20% | -$5.89M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.